INSR and Hyperinsulinemia: Hypothalamic dysfunction combined with decreased insulin receptors and altered mitochondrial bioenergetics in individuals with PWS30, 31, 32 may underlie the early increases in insulin secretion and subsequent hyperinsulinemia.